Hospitals & Providers
Aster DM Healthcare Plans ₹4,000 Crore Investment to Add 4,080 Hospital Beds
Expansion will support new hospitals and capacity additions across key cities as the company moves ahead with its merger with Quality Care India Ltd.
Aster DM Healthcare has announced plans to invest around ₹4,000 crore over the next few years to expand its hospital network and add approximately 4,080 beds, according to Founder and Chairman Azad Moopen.
The announcement comes as the company has received final shareholder approval for its proposed merger with Quality Care India Ltd (QCIL). Aster DM Healthcare stated that the merger is expected to be completed in the next quarter, subject to remaining regulatory and statutory approvals from the National Company Law Tribunal (NCLT).
"Looking ahead, India will remain a key growth market for the merged entity. We plan to add 4,080 beds over the next few years supported by a capital outlay of approximately ₹4,000 crore. Of these planned additions, 2,368 beds will be added by Aster DM and remaining by QCIL," Moopen said in a statement.
As part of the expansion strategy, the company plans to establish two new hospitals in Bengaluru, including a 430-bed facility on Sarjapur Road and a 500-bed hospital in Yeshwanthpur. Additional capacity expansion is also planned at Aster CMI Hospital, where 350 beds will be added, and Aster Whitefield, which will see an increase of 159 beds, the company said.
In Kerala, the 263-bed Aster Kasaragod Hospital became operational in October 2025. Meanwhile, construction is underway for the 454-bed greenfield Aster Capital Hospital in Thiruvananthapuram, along with a 100-bed expansion at Aster Medcity in Kochi.
Further projects include a 300-bed Women & Children's Hospital in Hyderabad and a 75-bed expansion at Aster Ramesh Hospital in Ongole, according to the company.
Over the coming years, the merged entity aims to expand its total capacity to over 14,710 beds, including the planned addition of more than 4,080 beds. Of these, 2,368 beds will be added by Aster DM Healthcare, while the remaining capacity expansion will be undertaken by Quality Care India Ltd.
Commenting on the shareholders’ approval of the merger, Moopen said, "The strong support from our shareholders reflects their confidence in the strategic rationale of this merger and the long-term value it will deliver." He further said, "By bringing together Aster DM Healthcare and Quality Care India, we are building a scaled, future-ready healthcare platform with the clinical depth, operational strength and governance framework required to serve millions of patients across the country." This partnership combines Aster's legacy of patient-centric care and physician leadership with the institutional strength and growth expertise of Blackstone, Moopen added.
Following the merger, Aster promoters and Blackstone will have equal representation on the board and jointly control the company, while independent directors will constitute 50% of the board.
Under the new leadership structure, Azad Moopen will continue as Executive Chairman, while Varun Khanna (Group MD, QCIL) is expected to take on the role of Managing Director and Group CEO.
The announcement comes as the company has received final shareholder approval for its proposed merger with Quality Care India Ltd (QCIL). Aster DM Healthcare stated that the merger is expected to be completed in the next quarter, subject to remaining regulatory and statutory approvals from the National Company Law Tribunal (NCLT).
"Looking ahead, India will remain a key growth market for the merged entity. We plan to add 4,080 beds over the next few years supported by a capital outlay of approximately ₹4,000 crore. Of these planned additions, 2,368 beds will be added by Aster DM and remaining by QCIL," Moopen said in a statement.
As part of the expansion strategy, the company plans to establish two new hospitals in Bengaluru, including a 430-bed facility on Sarjapur Road and a 500-bed hospital in Yeshwanthpur. Additional capacity expansion is also planned at Aster CMI Hospital, where 350 beds will be added, and Aster Whitefield, which will see an increase of 159 beds, the company said.
In Kerala, the 263-bed Aster Kasaragod Hospital became operational in October 2025. Meanwhile, construction is underway for the 454-bed greenfield Aster Capital Hospital in Thiruvananthapuram, along with a 100-bed expansion at Aster Medcity in Kochi.
Further projects include a 300-bed Women & Children's Hospital in Hyderabad and a 75-bed expansion at Aster Ramesh Hospital in Ongole, according to the company.
Over the coming years, the merged entity aims to expand its total capacity to over 14,710 beds, including the planned addition of more than 4,080 beds. Of these, 2,368 beds will be added by Aster DM Healthcare, while the remaining capacity expansion will be undertaken by Quality Care India Ltd.
Commenting on the shareholders’ approval of the merger, Moopen said, "The strong support from our shareholders reflects their confidence in the strategic rationale of this merger and the long-term value it will deliver." He further said, "By bringing together Aster DM Healthcare and Quality Care India, we are building a scaled, future-ready healthcare platform with the clinical depth, operational strength and governance framework required to serve millions of patients across the country." This partnership combines Aster's legacy of patient-centric care and physician leadership with the institutional strength and growth expertise of Blackstone, Moopen added.
Following the merger, Aster promoters and Blackstone will have equal representation on the board and jointly control the company, while independent directors will constitute 50% of the board.
Under the new leadership structure, Azad Moopen will continue as Executive Chairman, while Varun Khanna (Group MD, QCIL) is expected to take on the role of Managing Director and Group CEO.
Aster DM HealthcareHealthcare InfrastructureHealthcare Investment
